ClinicalTrials.gg
CompletedNCT07738653Updated Jul 31, 2026

Changes in Spatiotemporal Gait Parameters in Experienced Meditators

An interventional study of Meditation in Mindfulness and Gait Biomechanics, sponsored by Hospital Miguel Servet. Completed at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-31.

Sponsored by Hospital Miguel Servet · Not applicable, Interventional, and Screening

How we know

From the registry’s dates

  • Registered 3 years after the study started (first participant enrolled Jul 2023, registered Jul 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
13
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This research project aims to investigate whether participation in a 5-day meditation retreat is associated with changes in biomechanical gait parameters in experienced meditators. Walking is a complex motor function that integrates cognitive, sensory, and neuromuscular processes, and alterations in gait have been linked to neurological, psychological, and emotional functioning. Recent advances in wearable sensor technology enable precise assessment of gait characteristics, including stance and swing phases, foot-rocker timing, acceleration, and joint kinematics, providing objective measures of motor performance. Mindfulness has consistently demonstrated beneficial effects on psychological well-being, emotion regulation, and body awareness, and growing evidence suggests that emotional states influence motor behavior, including gait. Furthermore, mindfulness-based interventions have shown promising effects on motor symptoms in some clinical populations, although the underlying mechanisms remain poorly understood. Meditation retreats, which combine intensive mindfulness practice with a distraction-free environment, have been associated with sustained improvements in stress, anxiety, quality of life, and neuroplasticity-related processes. However, despite increasing interest in mind-body interventions, no published studies have specifically examined the effects of meditation retreats on gait biomechanics. This pilot study therefore seeks to address this knowledge gap by evaluating changes in gait and foot-strike biomechanics before and after a 5-day meditation retreat using wearable gait analysis technology. In addition, the study will explore the relationship between changes in biomechanical gait variables and participants' levels of mindfulness and quality of life. The findings are expected to provide preliminary evidence on the potential motor effects of intensive meditation practice and contribute to a better understanding of the interaction between mindfulness, body awareness, and locomotor function in healthy individuals.

Read the detailed description

Walking requires multiple and complex afferent and efferent networks-both cognitive and sensory-so that body weight can be borne alternately by both lower limbs, thereby achieving adequate overall bodily coordination . Some authors consider gait to be the "sixth vital sign", because gait disturbances in the absence of trauma may be prodromal features of neurodegeneration and contribute to disability in organic, psychological, and psychiatric disorders such as depression, thereby reducing quality of life In the last two decades, the development of sensors and wireless communication-based computing systems has complemented the information provided by classic observation-based parameters. This technology yields more detailed information in gait analysis by allowing measurement of stance and swing times, the duration of the three foot rockers (heel, ankle, and forefoot), maximal acceleration, and pronation-supination and flexion-extension angles.

Mindfulness is "a process of self-regulation of attention so that it is maintained on immediate experience, with an attitude of curiosity, openness, and acceptance toward that experience". It increases body awareness and helps reduce stress and anxiety by enabling individuals to become aware of thoughts and emotions without judgment through processes that affect emotion regulation . Mindfulness-based programs such as MBSR and MBCT have shown beneficial effects both in healthy individuals and in people with mental or physical illnesses associated with chronic pain, anxiety, or depression.

Emotional states affect the somatovisceral and motor systems, while the experience of bodily states influences emotional information processing . This occurs both in disease states and in healthy individuals . Recently, Wakabayashi et al. demonstrated that gait alone can convey emotional information, as observers were able to identify emotions such as anger, sadness, and fear from body movement in isolation. These gait-related patterns were captured through motion-capture sensor measurements obtained from 17 body regions. This finding suggests that different bodily experiences may shape gait and, in turn, influence the emotional information it communicates.

Reviews and meta-analyses indicate that mindfulness has shown beneficial effects not only on psychological symptoms but also on motor alterations in patients with Parkinson's disease , although a recent paper by Trinh et al. points out that the evidence is conflicting and not always significant . In other conditions, such as stroke rehabilitation, the evidence is weaker because it is difficult to disentangle the specific effect of mindfulness from that of other maneuvers affecting motor recovery, as also occurs in other organic diseases . This is partly because many medical conditions are associated with autonomic dysregulation, which may have a widespread negative impact on multiple body systems and lead to health deterioration, as noted by Churchill.

In healthy individuals, mindfulness improves overall health and quality of life, and some authors advocate its incorporation into health programs for older adults in order to promote more successful aging.

In the last decade, meditation retreats have proliferated in developed countries. These programs integrate relaxation with mindfulness by incorporating activities such as meditation, silence, diet, yoga, or similar practices. Participants seek serene, distraction-free environments that facilitate introspection. A systematic meta-analysis showed that traditional meditation retreats reduce anxiety, depression, and stress, and improve emotion regulation and quality of life, with sustained effects at follow-up and benefits that may last longer than those of conventional vacations . Another meta-analysis focused on Vipassana meditation supports these findings . Jinich-Diamant et al. observed that a 7-day intensive intervention focused on mind-body reconceptualization, meditation, and open-label placebo was associated with brain and molecular changes consistent with enhanced neuroplasticity and metabolic modulation. Although these findings suggest the biological potential of mind-body interventions, they should be interpreted with caution due to the absence of a control group.

This effect is not limited to healthy individuals: the American Heart Association recognizes that meditation, including retreats, may improve perceived stress, mood, and quality of life, although the strength of evidence is modest and more studies are required to define the underlying physiological mechanisms.

In summary, the medical literature supports that meditation retreats provide significant benefits for mental health and for some physical parameters, with sustained effects and a low risk of relevant adverse events. However, there is very little information on their motor neurological impact. Naranjo et al. found a positive effect on visuomotor integration processes after a task eliciting perceptual-motor conflict in the upper limbs. The authors suggested that greater connection with the body allows movement to be adjusted in real time, thereby improving precision and response. Nevertheless, information is still lacking regarding gait, where involvement of the lower limbs is essential.

After searching the terms "meditation retreat and/or mindfulness and gait and retreats" in Web of Science, Scopus, PubMed, PsycINFO, Google Scholar, Fisterra, MEDLINE OvidSP, EMBASE, and the Cochrane Library, we found no published studies analyzing this topic. It was therefore considered appropriate to conduct a pilot study in healthy meditators attending a retreat for meditative practice in order to assess possible changes in gait, given the interaction between emotional states and somatovisceral systems.

02

Conditions studied

  • Mindfulness
  • Gait Biomechanics
03

In context

Lead sponsor

Hospital Miguel Servet is the lead sponsor of 25 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Taking part in the meditation retreat
  • Being able to read and understand the Spanish language
  • Not have been diagnosed with any serious medical or psychiatric conditions
  • Not have been diagnosed with any condition that impairs or alters foot strike or gait

Exclusion criteria

Exclusion Criteria:

  • Age: \<18 years old
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
13 participants (actual)

Study arms

  • Experimental
    Meditators in Retreat

    Meditators participating in a 5-day retreat.

    Behavioral: Meditation

Interventions

  • BehavioralMeditation

    This is a 5-day meditation retreat during which participants take part in various practices.

06

What researchers measure

Primary outcomes

  1. Biomechanical Variables

    Inertial sensors: These sensors consist of accelerometers and gyroscopes that enable the estimation of foot movements. Electronic baropodometer: This is a device comprising a platform with digital sensors designed to assess the points of maximum pressure on the foot whilst stationary, as well as to analyse the feet whilst in motion, obtaining data on pressure, rotation and displacement.

    Time frame: Baseline

  2. 15-item Five Facet Mindfulness Questionnaire (FFMQ-15)

    The FFMQ is a test comprising 39 items, which measures the general tendency to practise mindfulness based on five skills: Observation, Description, Mindful Action, Non-judgement and Non-reactivity. This scale is valid and reliable, with a Cronbach's alpha coefficient of 0.84. Total scores range from 15 to 75, with higher scores indicating greater levels of mindfulness.

    Time frame: Baseline

  3. Generalized Anxiety Disorder-7 (GAD-7)

    Generalised Anxiety Disorder Scale (GAD-7): The GAD-7 is a tool that demonstrates adequate indicators of validity and reliability. It is an excellent, reliable, easy and quick-to-use tool for detecting symptoms of generalised anxiety; its internal consistency yielded a Cronbach's alpha of 0.88. Total scores range from 0 to 21, with higher scores indicating greater anxiety symptom severity. Scores of 0-4 indicate minimal anxiety, 5-9 mild anxiety, 10-14 moderate anxiety, and 15-21 severe anxiety.

    Time frame: Baseline

  4. Patient Health Questionnaire-9 (PHQ-9)

    Patient Health Questionnaire (PHQ-9): The PHQ-9 is a nine-item self-report measure that evaluates the presence of depressive symptoms based on the DSM-IV criteria for major depressive episode. This questionnaire demonstrates good internal consistency, with a Cronbach's alpha of 0.80. Total scores range from 0 to 27, with higher scores indicating greater depressive symptom severity. Scores of 0-4 indicate minimal depression, 5-9 mild depression, 10-14 moderate depression, 15-19 moderately severe depression, and 20-27 severe depression.

    Time frame: Baseline

  5. 12-Item Short Form Health Survey (SF-12)

    The SF-12 is a generic measure of health-related quality of life that evaluates physical, mental, and social health. It is a shortened version of the SF-36 and assesses the same eight health domains: Physical Functioning, Role Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role Emotional, and Mental Health. Domain scores are transformed to a 0-100 scale, where 0 represents the worst possible health status and 100 the best possible health status. Higher scores indicate better perceived health-related quality of life. The SF-12 also provides Physical Component Summary (PCS) and Mental Component Summary (MCS) scores.

    Time frame: Baseline

  6. Visual Analogue Scale (VAS)

    The Visual Analogue Scale (VAS) is a single-item self-report measure used to assess the intensity of emotional states. Each emotion is rated on a 0-10 scale, with higher scores indicating greater emotional intensity. In this study, the VAS was used to assess the intensity of happiness, sadness, anger, surprise, anxiety, relaxation/calm, and vigor/energy. A score of 0 indicates the complete absence of the emotion, whereas a score of 10 indicates the maximum intensity of that emotion.

    Time frame: Baseline

  7. Biomechanical Variables

    Inertial sensors: These sensors consist of accelerometers and gyroscopes that enable the estimation of foot movements. Electronic baropodometer: This is a device comprising a platform with digital sensors designed to assess the points of maximum pressure on the foot whilst stationary, as well as to analyse the feet whilst in motion, obtaining data on pressure, rotation and displacement.

    Time frame: Up to 5 days

  8. 15-item Five Facet Mindfulness Questionnaire (FFMQ-15)

    The FFMQ is a test comprising 39 items, which measures the general tendency to practise mindfulness based on five skills: Observation, Description, Mindful Action, Non-judgement and Non-reactivity. This scale is valid and reliable, with a Cronbach's alpha coefficient of 0.84. Total scores range from 15 to 75, with higher scores indicating greater levels of mindfulness.

    Time frame: Up to 5 days

  9. Generalized Anxiety Disorder-7 (GAD-7)

    Generalised Anxiety Disorder Scale (GAD-7): The GAD-7 is a tool that demonstrates adequate indicators of validity and reliability. It is an excellent, reliable, easy and quick-to-use tool for detecting symptoms of generalised anxiety; its internal consistency yielded a Cronbach's alpha of 0.88. Total scores range from 0 to 21, with higher scores indicating greater anxiety symptom severity. Scores of 0-4 indicate minimal anxiety, 5-9 mild anxiety, 10-14 moderate anxiety, and 15-21 severe anxiety.

    Time frame: Up to 5 days

  10. Patient Health Questionnaire (PHQ-9)

    Patient Health Questionnaire (PHQ-9): The PHQ-9 is a nine-item self-report measure that evaluates the presence of depressive symptoms based on the DSM-IV criteria for major depressive episode. This questionnaire demonstrates good internal consistency, with a Cronbach's alpha of 0.80. Total scores range from 0 to 27, with higher scores indicating greater depressive symptom severity. Scores of 0-4 indicate minimal depression, 5-9 mild depression, 10-14 moderate depression, 15-19 moderately severe depression, and 20-27 severe depression.

    Time frame: Up to 5 days

  11. 12-Item Short Form Health Survey (SF-12)

    The SF-12 is a generic measure of health-related quality of life that evaluates physical, mental, and social health. It is a shortened version of the SF-36 and assesses the same eight health domains: Physical Functioning, Role Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role Emotional, and Mental Health. Domain scores are transformed to a 0-100 scale, where 0 represents the worst possible health status and 100 the best possible health status. Higher scores indicate better perceived health-related quality of life. The SF-12 also provides Physical Component Summary (PCS) and Mental Component Summary (MCS) scores.

    Time frame: Up to 5 days

  12. Visual Analogue Scale (VAS)

    The Visual Analogue Scale (VAS) is a single-item self-report measure used to assess the intensity of emotional states. Each emotion is rated on a 0-10 scale, with higher scores indicating greater emotional intensity. In this study, the VAS was used to assess the intensity of happiness, sadness, anger, surprise, anxiety, relaxation/calm, and vigor/energy. A score of 0 indicates the complete absence of the emotion, whereas a score of 10 indicates the maximum intensity of that emotion.

    Time frame: Up to 5 days

Secondary outcomes

  1. Gender

    Gender of participants: male, female, other.

    Time frame: Baseline

  2. Age

    Open-ended question where subjects are asked to indicate numerically their current age.

    Time frame: Baseline

  3. Nationality

    Country of birth of participants: Spain, other (please specify).

    Time frame: Baseline

  4. Current city of residence

    Place of current residence

    Time frame: Baseline

  5. Cohabitation

    Who do you live with

    Time frame: Baseline

  6. Education

    Level of education completed

    Time frame: Baseline

  7. Employment situation

    Current employment status

    Time frame: Baseline

  8. Meditative practice

    A meditation practice questionnaire will be administered to collect detailed information about participants' meditation experience. Specifically, it assesses the onset of meditation practice (e.g., when participants began meditating), the way in which they learned or were introduced to meditation (e.g., through formal courses, retreats, self-guided learning, or teachers), and the characteristics of their current practice. The questionnaire also gathers information on the frequency and duration of meditation, including the amount of time devoted to different types of practices (e.g., focused attention, open monitoring, loving-kindness, body scan, or other meditation techniques), providing a comprehensive overview of each participant's meditation background and habits.

    Time frame: Baseline

  9. Body weight

    Participants were asked to self-report their current body weight in kilograms (kg). Higher values indicate greater body weight.

    Time frame: Baseline

  10. Height

    Participants were asked to self-report their height in centimeters (cm). Higher values indicate greater stature.

    Time frame: Baseline

07

Study locations

1 site
  • Department of Psychiatry. Miguel Servet University Hospital, Zaragoza, Zaragoza 50009
    Zaragoza, Spain
08

References and documents

Publications

  • Wang S, Zhang C, Xu W. Mindfulness, mortality, disability rates, physical and mental health among the oldest old. Health Psychol. 2023 Oct;42(10):746-755. doi: 10.1037/hea0001315. Epub 2023 Aug 24. PubMed 37616101 ↗
  • Verhaeghen P, Aikman SN, Mirabito G. Mindfulness Interventions in Older Adults for Mental Health and Well-Being: A Meta-Analysis. J Gerontol B Psychol Sci Soc Sci. 2025 Mar 12;80(4):gbae205. doi: 10.1093/geronb/gbae205. PubMed 39708291 ↗
  • Trinh J, de Vries NM, Chan P, Dekker MCJ, Helmich RC, Bloem BR. The role of lifestyle interventions in symptom management and disease modification in Parkinson's disease. Lancet Neurol. 2026 Jan;25(1):90-102. doi: 10.1016/S1474-4422(25)00305-9. Epub 2025 Oct 15. PubMed 41109323 ↗
  • Takakusaki K. Functional Neuroanatomy for Posture and Gait Control. J Mov Disord. 2017 Jan;10(1):1-17. doi: 10.14802/jmd.16062. Epub 2017 Jan 18. PubMed 28122432 ↗
  • Sloman L, Berridge M, Homatidis S, Hunter D, Duck T. Gait patterns of depressed patients and normal subjects. Am J Psychiatry. 1982 Jan;139(1):94-7. doi: 10.1176/ajp.139.1.94. PubMed 7055284 ↗
  • Schlechta Portella CF, Ghelman R, Abdala V, Schveitzer MC, Afonso RF. Meditation: Evidence Map of Systematic Reviews. Front Public Health. 2021 Dec 2;9:742715. doi: 10.3389/fpubh.2021.742715. eCollection 2021. PubMed 34926371 ↗
  • Prakash RS, Whitmoyer P, Aldao A, Schirda B. Mindfulness and emotion regulation in older and young adults. Aging Ment Health. 2017 Jan;21(1):77-87. doi: 10.1080/13607863.2015.1100158. Epub 2015 Nov 4. PubMed 26537859 ↗
  • Niedenthal PM. Embodying emotion. Science. 2007 May 18;316(5827):1002-5. doi: 10.1126/science.1136930. PubMed 17510358 ↗
  • Mirelman A, Shema S, Maidan I, Hausdorff JM. Gait. Handb Clin Neurol. 2018;159:119-134. doi: 10.1016/B978-0-444-63916-5.00007-0. PubMed 30482309 ↗
  • Michalak J, Rohde K, Troje NF. How we walk affects what we remember: gait modifications through biofeedback change negative affective memory bias. J Behav Ther Exp Psychiatry. 2015 Mar;46:121-5. doi: 10.1016/j.jbtep.2014.09.004. Epub 2014 Sep 28. PubMed 25310681 ↗
  • Mak TCT, Wong TWL, Ng SSM. The use of mindfulness-based interventions in stroke rehabilitation: A scoping review. Rehabil Psychol. 2023 Aug;68(3):221-234. doi: 10.1037/rep0000505. Epub 2023 Jun 1. PubMed 37261753 ↗
  • Lin HW, Tam KW, Kuan YC. Mindfulness or meditation therapy for Parkinson's disease: A systematic review and meta-analysis of randomized controlled trials. Eur J Neurol. 2023 Aug;30(8):2250-2260. doi: 10.1111/ene.15839. Epub 2023 May 21. PubMed 37158296 ↗
  • Levine GN, Lange RA, Bairey-Merz CN, Davidson RJ, Jamerson K, Mehta PK, Michos ED, Norris K, Ray IB, Saban KL, Shah T, Stein R, Smith SC Jr; American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Hypertension. Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart Association. J Am Heart Assoc. 2017 Sep 28;6(10):e002218. doi: 10.1161/JAHA.117.002218. PubMed 28963100 ↗
  • Lemke MR, Wendorff T, Mieth B, Buhl K, Linnemann M. Spatiotemporal gait patterns during over ground locomotion in major depression compared with healthy controls. J Psychiatr Res. 2000 Jul-Oct;34(4-5):277-83. doi: 10.1016/s0022-3956(00)00017-0. PubMed 11104839 ↗
  • Khoury B, Knauper B, Schlosser M, Carriere K, Chiesa A. Effectiveness of traditional meditation retreats: A systematic review and meta-analysis. J Psychosom Res. 2017 Jan;92:16-25. doi: 10.1016/j.jpsychores.2016.11.006. Epub 2016 Nov 18. PubMed 27998508 ↗
  • Kang GE, Mickey BJ, McInnis MG, Krembs BS, Gross MM. Motor behavior characteristics in various phases of bipolar disorder revealed through biomechanical analysis: Quantitative measures of activity and energy variables during gait and sit-to-walk. Psychiatry Res. 2018 Nov;269:93-101. doi: 10.1016/j.psychres.2018.08.062. Epub 2018 Aug 17. PubMed 30145308 ↗
  • Jinich-Diamant A, Simpson S, Zuniga-Hertz JP, Chitteti R, Schilling JM, Bonds JA, Case L, Chernov AV, Dispenza J, Maree J, Amkie Stahl NE, Licamele M, Fazlalipour N, Devulapalli S, Christov-Moore L, Reggente N, Poirier MA, Moeller-Bertram T, Patel HH. Neural and molecular changes during a mind-body reconceptualization, meditation, and open label placebo healing intervention. Commun Biol. 2025 Nov 6;8(1):1525. doi: 10.1038/s42003-025-09088-3. PubMed 41198896 ↗
  • Jin X, Wang L, Liu S, Zhu L, Loprinzi PD, Fan X. The Impact of Mind-body Exercises on Motor Function, Depressive Symptoms, and Quality of Life in Parkinson's Disease: A Systematic Review and Meta-analysis. Int J Environ Res Public Health. 2019 Dec 18;17(1):31. doi: 10.3390/ijerph17010031. PubMed 31861456 ↗
  • Homagain A, Ehgoetz Martens KA. Emotional states affect steady state walking performance. PLoS One. 2023 Sep 14;18(9):e0284308. doi: 10.1371/journal.pone.0284308. eCollection 2023. PubMed 37708145 ↗
  • He S, Fang W, Wu J, Lv H, Zhang J, Wang T, Huang Y, Li G, Li M. Whether mindfulness-guided therapy can be a new direction for the rehabilitation of patients with Parkinson's disease: a network meta-analysis of non-pharmacological alternative motor-/sensory-based interventions. Front Psychol. 2023 Sep 14;14:1162574. doi: 10.3389/fpsyg.2023.1162574. eCollection 2023. PubMed 37780170 ↗
  • Hausdorff JM, Buchman AS. What links gait speed and MCI with dementia? A fresh look at the association between motor and cognitive function. J Gerontol A Biol Sci Med Sci. 2013 Apr;68(4):409-11. doi: 10.1093/gerona/glt002. Epub 2013 Feb 11. No abstract available. PubMed 23401565 ↗
  • Gomez Bernal A, Becerro-de-Bengoa-Vallejo R, Losa-Iglesias ME. Reliability of the OptoGait portable photoelectric cell system for the quantification of spatial-temporal parameters of gait in young adults. Gait Posture. 2016 Oct;50:196-200. doi: 10.1016/j.gaitpost.2016.08.035. Epub 2016 Sep 13. PubMed 27644096 ↗
  • Giridharan S, Soumian S, Kumar NV, Godbole M. The Impact of Vipassana Meditation on Health and Well-Being: A Systematic Review of Current Evidence. Cureus. 2025 Sep 27;17(9):e93355. doi: 10.7759/cureus.93355. eCollection 2025 Sep. PubMed 41158896 ↗
  • Drahota A, Udell JE, Mackenzie H, Pugh MT. Psychological and educational interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2024 Oct 3;10(10):CD013480. doi: 10.1002/14651858.CD013480.pub2. PubMed 39360568 ↗
  • Deligianni F, Guo Y, Yang GZ. From Emotions to Mood Disorders: A Survey on Gait Analysis Methodology. IEEE J Biomed Health Inform. 2019 Nov;23(6):2302-2316. doi: 10.1109/JBHI.2019.2938111. Epub 2019 Sep 9. PubMed 31502995 ↗
  • Churchill R, Swartz B, Johnston-Dumerauf A, Halaris A. The Impact of Mindfulness-Based Interventions on Objective Physiological Measures of Autonomic Function for Individuals With Medical Conditions: A Review of the Evidence. Psychosom Med. 2024 Jan 1;86(1):2-10. doi: 10.1097/PSY.0000000000001260. Epub 2023 Nov 13. PubMed 37982538 ↗
  • Blasche G, deBloom J, Chang A, Pichlhoefer O. Is a meditation retreat the better vacation? effect of retreats and vacations on fatigue, emotional well-being, and acting with awareness. PLoS One. 2021 Feb 8;16(2):e0246038. doi: 10.1371/journal.pone.0246038. eCollection 2021. PubMed 33556137 ↗
  • Naranjo JR, Schmidt S. Is it me or not me? Modulation of perceptual-motor awareness and visuomotor performance by mindfulness meditation. BMC Neurosci. 2012 Jul 30;13:88. doi: 10.1186/1471-2202-13-88. PubMed 22846109 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jul 2023 to primary completion in Jul 2023, 0 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 21, 2026
First posted
Jul 31, 2026
StartActual
Jul 18, 2023
Primary completionActual
Jul 23, 2023
CompletionActual
Jul 23, 2023
Last update
Jul 31, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 31, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07738653
Lead sponsor
Hospital Miguel Servet
Collaborators
Fundacion Podoactiva
Responsible party
Javier Garcia Campayo (Principal Investigator, Hospital Miguel Servet) — Principal investigator
First posted
Jul 31, 2026
Start date
Jul 18, 2023
Primary completion
Jul 23, 2023
Completion
Jul 23, 2023
Last update
Jul 31, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion